Literature DB >> 9018972

Cytokines, tumour-cell death and immunogenicity: a question of choice.

P Musiani1, A Modesti, M Giovarelli, F Cavallo, M P Colombo, P L Lollini, G Forni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9018972     DOI： 10.1016/s0167-5699(97)80012-6

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  18 in total

Review 1.  Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies.

Authors:  V Schmitz; C Qian; J Ruiz; B Sangro; I Melero; G Mazzolini; I Narvaiza; J Prieto
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

Review 2.  One microenvironment does not fit all: heterogeneity beyond cancer cells.

Authors:  Ik Sun Kim; Xiang H-F Zhang
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

3.  Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response.

Authors:  C Rozera; D Carlei; P L Lollini; C De Giovanni; P Musiani; E Di Carlo; F Belardelli; M Ferrantini
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

4.  Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene-transduced tumor cells.

Authors:  I Rossi; G Nicoletti; L Landuzzi; F Frabetti; C De Giovanni; P Nanni; P Musiani; M Ferrantini; F Belardelli; P L Lollini
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

5.  Combined gene therapy of endostatin and interleukin 12 with polyvinylpyrrolidone induces a potent antitumor effect on hepatoma.

Authors:  Pei-Yuan Li; Ju-Sheng Lin; Zuo-Hua Feng; Yu-Fei He; He-Jun Zhou; Xin Ma; Xiao-Kun Cai; De-An Tian
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

6.  Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas.

Authors:  Claudia Curcio; Emma Di Carlo; Raphael Clynes; Mark J Smyth; Katia Boggio; Elena Quaglino; Michela Spadaro; Mario P Colombo; Augusto Amici; Pier-Luigi Lollini; Piero Musiani; Guido Forni
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

7.  Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.

Authors:  Elena Quaglino; Simona Rolla; Manuela Iezzi; Michela Spadaro; Piero Musiani; Carla De Giovanni; Pier Luigi Lollini; Stefania Lanzardo; Guido Forni; Remo Sanges; Stefania Crispi; Pasquale De Luca; Raffaele Calogero; Federica Cavallo
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

8.  Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site.

Authors:  Qiang Zhou; Bryon D Johnson; Rimas J Orentas
Journal:  Cell Immunol       Date:  2007-06-01       Impact factor: 4.868

9.  Preclinical HER-2 Vaccines: From Rodent to Human HER-2.

Authors:  Pier-Luigi Lollini; Carla De Giovanni; Patrizia Nanni
Journal:  Front Oncol       Date:  2013-06-10       Impact factor: 6.244

10.  Synergistic antitumour effects of chemo-immunotherapy with an oxazaphosphorine drug and IL-2-secreting cells in a mouse colon cancer model.

Authors:  H Kusnierczyk; E Pajtasz-Piasecka; C Radzikowski
Journal:  Med Oncol       Date:  1999-12       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.